US 11401346
Nucleic acids encoding plasma kallikrein binding proteins
granted A61KA61K2039/505A61P
Quick answer
US patent 11401346 (Nucleic acids encoding plasma kallikrein binding proteins) held by Takeda Pharmaceutical Company Limited expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/02